Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab maintenance vs observation in high tumor burden follicular lymphoma
CTR20140026Phase 3Active
- Sponsor
- Roche
- Start
- May 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in follicular lymphoma (FL), sponsored by Roche. Started May 2014; status: active.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on CTR20140026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140026.